Hopital Leopold Bellan
- Address
- 19 Rue Vercingetorix, 75014 Paris, France
Hopital Leopold Bellan - Alzheimer's Disease and Cognitive Health Research
Hopital Leopold Bellan is a clinical research facility specializing in neurodegenerative disease research, with a particular focus on Alzheimer's disease and cognitive health management. The center conducts comparative effectiveness studies evaluating both pharmacological and non-pharmacological approaches to dementia care.
- Alzheimer's disease treatment optimization and cognitive enhancement strategies
- Comparative studies of cholinesterase inhibitors versus non-drug interventions
- Evidence-based evaluation of integrated care pathways for dementia patients
The research center is committed to advancing the understanding of optimal therapeutic approaches for Alzheimer's disease, including investigations into the efficacy of donepezil and other acetylcholinesterase inhibitors. Their clinical trials assess cognitive outcomes and quality of life measures, aiming to establish best practices in dementia care that combine pharmacological treatments with comprehensive non-medicinal management strategies.
Site Overview
Activity Indicator
Last 6 months
Trial Flow
How this site's trials are distributed across therapeutic areas and active substances (IMPs), and how they're positioned within their overall lifecycle status. Flow thickness represents the number of unique trials.
Compounds & Molecules Timeline
The time span of clinical-trial activity for the main active substances (IMPs) studied at this site over the last 8 years. Each bar runs from the earliest trial start to the most recent end; a substance with a trial still open has no recorded end and is shown as ongoing.
Sponsor & Partnership
Top sponsors by active trials, and the ones that have come back for more than one study.
Sponsor Network
Top 1 by active trials.
Partnership History
Sponsors with repeated collaboration (≥ 2 trials).
No repeated partnerships found.
Sponsor Network Graph
How sponsors and therapeutic areas connect across this site's active trials: each link is at least one active trial shared between them, and bigger nodes mean more activity. Click a node to see its exact connections.
Country Benchmark
Compared to 978 other sites in France
Therapeutic Area Benchmark — France
Select a therapeutic area to compare against other sites in France.
Competitor Comparison
Similar sites in the same country running a comparable number of trials (within ±30%), scored on how closely their trial portfolios match this one. Higher percentages mean a more similar profile.
Country: France
Market Share
Country: France
Therapeutic Area Market Share
Select a therapeutic area to view its disease coverage breakdown.
Heat Maps & Advanced Analytics
How often specific conditions appear in trials across this site and comparable sites from the same country. Each row is a site, each column a condition, and each cell the number of trials on it — darker means more activity.
Other Trials in Hopital Leopold Bellan
| Trial | Sponsor | Phase | Status | Start Date | End Date |
|---|---|---|---|---|---|
| Evaluation of Donepezil Versus Non-Pharmacological Management in Patients with Alzheimer's Disease: A Randomized Controlled Trial | Assistance Publique Hopitaux De Paris | Phase III | Recruiting | Feb 2022 | — |
IMP list
| IMP | Trials | Status | First start | Last start |
|---|---|---|---|---|
| Donepezil | 1 | Unknown | 2022-02-10 | 2022-02-10 |
Request feasibility information
Ask this centre about capacity, equipment and patient population.
Upgrade this site to Business Plan
Own the profile, publish your feasibility data and reach sponsors directly.
Is something out of date?
Tell us what needs correcting and we'll update this profile.
lock Available to Business plan sites only.